Literature DB >> 7536467

De novo development and self-replenishment of B cells.

A B Kantor1, A M Stall, S Adams, K Watanabe, L A Herzenberg.   

Abstract

Previous studies distinguished two murine B cell lineages: the conventional lineage, which comprises the majority of B cells, and the Ly-1 B lineage (B-1a), which represents a small percentage of total adult B cells. A third subset, B-1b cells, shares many properties with B-1a cells, including the characteristic ability to self-replenish, but does not express Ly-1 (CD5). Reconstitution studies presented here show that (i) although the B220- population in adult spleen and bone marrow contains very little progenitor activity for B-1a cells, it can reconstitute roughly half the normal number of B-1b cells; (ii) B-1 progenitors present in adult bone marrow and spleen function at low levels in adult animals; (iii) peritoneal B-1 cells (principally B-1b) that develop following bone marrow transfer, like B-1 cells from normal animals, are capable of substantial self-replenishment; and (iv) conventional B cells do not expand (self-replenish) in adoptive recipients, although they can persist for long periods. Collectively, these progenitor and self-replenishment characteristics provide a developmental base for distinguishing B-1a, B-1b and conventional B cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536467     DOI: 10.1093/intimm/7.1.55

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  28 in total

1.  CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools.

Authors:  N Baumgarth; G C Jager; O C Herman; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

Review 2.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

3.  Distinct B-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells.

Authors:  Eliver Eid Bou Ghosn; Ryo Yamamoto; Sanae Hamanaka; Yang Yang; Leonard A Herzenberg; Hiromitsu Nakauchi; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

Review 4.  B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies.

Authors:  Carl S Goodyear; Gregg J Silverman
Journal:  Springer Semin Immunopathol       Date:  2005-03

5.  Distinct progenitors for B-1 and B-2 cells are present in adult mouse spleen.

Authors:  Eliver Eid Bou Ghosn; Patricia Sadate-Ngatchou; Yang Yang; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

6.  Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.

Authors:  M Fischer; U Klein; R Küppers
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

7.  Induction of murine CD5 expression by v-H-ras.

Authors:  T R Weichert; R C Schwartz
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

8.  Reduced production of B-1-specified common lymphoid progenitors results in diminished potential of adult marrow to generate B-1 cells.

Authors:  Chad L Barber; Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

9.  Formation of B-1 B cells from neonatal B-1 transitional cells exhibits NF-κB redundancy.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  J Immunol       Date:  2011-10-26       Impact factor: 5.422

10.  Changes of cytosolic [Ca2+]i in neutrophils in pancreatic microcirculation of rats with caerulein-induced acute pancreatitis under fluid shear stress.

Authors:  Zong-Guang Zhou; You-Qin Chen; Xu-Bao Liu; Wei-Ming Hu; Bo-Le Tian; Huai-Qing Chen
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.